Unmet medical needs are not infrequent in oncology, and these needs are usually of higher magnitude in rare cancers. The field of neuroendocrine neoplasms (NENs) has evolved rapidly during the last decade, and, currently, a new WHO classification is being implemented and several treatment options are available in the metastatic setting after the results of prospective phase III clinical trials. However, several questions are still unanswered, and decisions in our daily clinical practice should be made with limited evidence. In the 2016 meeting of the advisory board of the European Neuroendocrine Tumor Society (ENETS), the main unmet medical needs in the metastatic NENs setting were deeply discussed, and several proposals to try to solve them are presented in this article, including biomarkers, imaging, and therapy.

Unmet medical needs · Neuroendocrine neoplasms · Metastasis · Biomarkers · Imaging · Therapy
dx.doi.org/10.1159/000493319, hdl.handle.net/1765/127172
Neuroendocrinology: international journal for basic and clinical studies on neuroendocrine relationships

Capdevila, J, Bodei, L, Davies, P, Gorbounova, V., Jensen, R.T, & Knigge, U.P. (2019). Unmet Medical Needs in Metastatic Lung and Digestive Neuroendocrine Neoplasms. Neuroendocrinology: international journal for basic and clinical studies on neuroendocrine relationships, 108(1), 18–25. doi:10.1159/000493319